Asthma, airway biology, and allergic rhinitis in AJRCCM 2000. (Q34446626)

2 August 2017

1 reference

title

Asthma, airway biology, and allergic rhinitis in AJRCCM 2000. (English)

1 reference

2 August 2017

1 reference

1 reference

Tobin MJ

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

American Journal of Respiratory and Critical Care Medicine

2 August 2017

published in

1 reference

2 August 2017

volume

164

1 reference

2 August 2017

issue

9

1 reference

2 August 2017

page(s)

1559-1580

1 reference

Association of beta(2)-adrenoreceptor variants with bronchial hyperresponsiveness.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Association study of the chromosomal region containing the FCER2 gene suggests it has a regulatory role in atopic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Independent inheritance of serum immunoglobulin E concentrations and airway responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

beta(2)-adrenergic receptor Arg16/Arg16 genotype is associated with reduced lung function, but not with asthma, in the Hutterites

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Application of an algorithm for the diagnosis of asthma in Chinese families: limitations and alternatives for the phenotypic assessment of asthma in family-based genetic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Interactions between corticosteroids and beta-adrenergic agonists in asthma disease induction, progression, and exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

beta(2)-adrenergic receptor pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

The genetics of asthma. The important questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

What determines asthma phenotype? Is it the interaction between allergy and the smooth muscle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

What determines asthma phenotype? Respiratory infections and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Asthma mortality in U.S. Hispanics of Mexican, Puerto Rican, and Cuban heritage, 1990-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Differences in incidence of reported asthma related to age in men and women. A retrospective analysis of the data of the European Respiratory Health Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Relation between phase of menstrual cycle and emergency department visits for acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Nitric oxide synthase inhibitors attenuate ozone-induced airway inflammation in guinea pigs. Possible role of interleukin-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Endogenous airway acidification. Implications for asthma pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Airway nitric oxide diffusion in asthma: Role in pulmonary function and bronchial responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Exhaled nitric oxide following leukotriene E(4) and methacholine inhalation in patients with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Elevation of exhaled ethane concentration in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Effect of endogenous and exogenous prostaglandin E(2) on interleukin-1 beta-induced cyclooxygenase-2 expression in human airway smooth-muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

New aspects of degranulation and fates of airway mucosal eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Key factors in the development of asthma: atopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Endogenous inhibitory mechanisms in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Why does airway inflammation persist? Is it failure to treat early?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Why does airway inflammation persist? Is it leukotrienes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Specific IgE and IgG responses in atopic versus nonatopic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Gene knockout models of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

The road to the production of IgE is long and winding

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Regulation of interleukin 4 gene transcription: alterations in atopic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

One cytokine, two isotypes: a trojan horse, pandora's box, and an evolving paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Primary sensitization to inhalant allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Viruses and atopic sensitization in the first years of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Immune parameters in high-risk atopic individuals during early childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Perinatal events in relation to sensitization in the human

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Viral infections and childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Bronchial epithelium as a key regulator of airway allergen sensitization and remodeling in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

The genetics of atopy and airway hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Determinants of clinical allergic disease. The relevance of indoor allergens to the increase in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Atopy as a risk factor for chronic obstructive pulmonary disease: epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Innate immune system damage in human immunodeficiency virus type 1 infection. Implications for acquired immunity and vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Antigen-presenting cells. Experimental and clinical studies of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Regulation of helper T cell differentiation and recruitment in airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

gammadelta cells and the regulation of mucosal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

21 January 2018

Costimulation of T cells

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Immunological tolerance to inhaled antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Biotherapeutic targets for the treatment of allergic airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Control of experimental inflammatory bowel disease by regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Antigen presentation and DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Gene delivery to the corneal endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Prolonged allergen exposure induces structural airway changes in sensitized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Airway inflammation driven by antigen-specific resident lung CD4(+) T cells in alphabeta-T cell receptor transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Virus- and bradykinin-induced airway hyperresponsiveness in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Heparin inhibits eicosanoid metabolism and hyperventilation-induced bronchoconstriction in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Smooth-muscle myosin light-chain kinase content is increased in human sensitized airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Human isolated bronchial smooth muscle contains functional ryanodine/caffeine-sensitive Ca-release channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Epithelial desquamation in asthma: artifact or pathology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Predictors of late asthmatic response. Logistic regression and classification tree analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Pulmonary capillary blood volume in hyperpnea-induced bronchospasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

What is the relationship between airway hyperresponsiveness and atopy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Airway smooth muscle in asthma. Perturbed equilibria of myosin binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Deciphering the homeokinetic code of airway smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

What makes the airways contract abnormally? Is it inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Airway remodeling in asthma. Unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Airway hyperresponsiveness to cigarette smoke in ovalbumin-sensitized guinea pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Toluene diisocyanate enhances substance P in sensory neurons innervating the nasal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Nerve growth factor-induced phenotypic switch in guinea pig airway sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Responses of tracheobronchial receptors to inhaled furosemide in anesthetized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Dichotomy between neurokinin receptor actions in modulating allergic airway responses in an animal model of helper T cell type 2 cytokine-associated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Trypsin-induced, neurokinin-mediated contraction of guinea pig bronchus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Deep inspiration-induced bronchoprotection is stronger than bronchodilation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Effects of cool, dry air stimulation on peripheral lung mechanics in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Airway narrowing in healthy humans inhaling methacholine without deep inspirations demonstrated by HRCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

An analysis algorithm for measuring airway lumen and wall areas from high-resolution computed tomographic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Central airways behave more stiffly during forced expiration in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Unsuspected pseudophysiologic emphysema in chronic persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Asthma. From bronchoconstriction to airways inflammation and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

The risk of myocardial infarction associated with inhaled beta-adrenoceptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Transcriptional potencies of inhaled glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Inhaled budesonide decreases airway inflammatory response to allergen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Prolonged airway activity and improved selectivity of budesonide possibly due to esterification

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

The discovery of the leukotrienes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

From bench to bedside. The hurdles of discovering a new leukotriene receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

The molecular biology and regulation of 5-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Leukotriene C4 synthase. A pivotal enzyme in the biosynthesis of the cysteinyl leukotrienes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Membrane-associated proteins in eicosanoid and glutathione metabolism (MAPEG). A widespread protein superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Structure, function, and regulation of leukotriene A4 hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Phospholipase A2 in eicosanoid generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Intracellular compartmentalization of leukotriene biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Pharmacological characterization of leukotriene receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Binding to cysteinyl-leukotriene receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Leukotriene B4 receptor. Cloning and intracellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Cloning of a novel chemoattractant receptor activated by leukotriene B4 and used by human immunodeficiency virus type 1 to infect CD4-positive immune cells. A therapeutic connection to asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

The role of leukotrienes in the regulation of tone and responsiveness in isolated human airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Leukotriene bronchoconstriction induced by allergen and exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Effects of antileukotrienes in the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Genetic variations in the 5-lipoxygenase core promoter. Description and functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

The metabolism of leukotriene B4 in Lewis lung carcinoma porcine kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Adenosine, a potent natural suppressor of arachidonic acid release and leukotriene biosynthesis in human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Formation of endogenous "antiinflammatory" lipid mediators by transcellular biosynthesis. Lipoxins and aspirin-triggered lipoxins inhibit neutrophil recruitment and vascular permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Measurement of leukotrienes in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Functional studies of leukotriene receptors in vascular tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Interactions between leukotrienes and other inflammatory mediators/modulators in the microvasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

5-Lipoxygenase and leukotrienes. Transgenic mouse and nuclear targeting studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

21 January 2018

Leukotrienes in rhinitis

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Treatment of aspirin-intolerant asthma with antileukotrienes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Genetic mechanisms in aspirin-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Antileukotriene therapy. Future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Airway-parenchyma uncoupling in nocturnal asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Measuring asthma control. Clinic questionnaire or daily diary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Duration of asthma and physiologic outcomes in elderly nonsmokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Individual characteristics and quitting in apprentices exposed to high-molecular-weight agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Hospitalization among workers compensated for occupational asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Quality of life in allergic rhinitis and asthma. A population-based study of young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Ipratropium bromide increases the ability of the nose to warm and humidify air.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Genome Screen for Asthma and Related Phenotypes in the French EGEA Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Sputum Cysteinyl Leukotrienes Increase 24 Hours after Allergen Inhalation in Atopic Asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Induced Sputum Inflammatory Mediator Concentrations in Eosinophilic Bronchitis and Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Lung Deposition of Inhaled Drugs Increases with Age

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

Expression of Heme Oxygenase Isoenzymes 1 and 2 in Normal and Asthmatic Airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.9.2108114

10.1164/AJRCCM.164.9.2108114

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference